M&M reported 2QFY22 net revenue of Rs. 133bn, up 15%, YoY, EBITDA margins grew at 12.5%, and PAT stood at Rs. 17bn which was impacted due to an impairment of Rs. 2.5bn. M&M reported a loss of c32K units of SUV volumes owing to the semiconduct

In Q2FY22, the company generated net profit of Rs. 6,970mn, down by 13.5% YoY and down by 9.5% QoQ. This effect mainly came from the elevated generic price erosion in the US as channels try to liquidate excess stocks, putting pressure on prices. 

In the concall hosted by Mr Sumant Kathpalia, MD & CEO of IndusInd Bank, stated that the recent allegations against the bank regarding the evergreening of loans in its MFI subsidiary (Bharat Financial Inclusion Limited – BFIL) and the disbursem

Divis Lab’s Q2FY22 growth was majorly driven by Custom synthesis segment and Nutraceuticals segment. The overall revenue growth was a robust 40% YoY to Rs. 20bn in 1HFY22, while for the same time period, Generic API segment suffered by declining to

India sales increased 15.6% YoY at Rs. 24.2bn on core therapies growth but decreased 10.8% QoQ on account of lower COVID-19 sales. Cipla believes the broader Indian pharmaceuticals market (IPM) can sustain 10-12% annual sales growth without any obs

Bajaj Finance reported AUM growth of 22% YoY and 5% QoQ, 7-12% QoQ growth in consumer durables, personal loans, SME and rural segments, operating costs increased 76% YoY and 48% QoQ led by higher collection costs, increased manpower and branch additi

ITC's 2QFY22 performance was driven by recovery in cigarette volumes and strong performance in the paperboard segment. Overall net sales stood at Rs. 1,27,310mn grew 13.8% YoY and 4.2% QoQ, PAT stood at Rs. 36,972mn, grew 14.4% YoY and 22.7% QoQ, and

Titan's robust margin expansion and earnings growth was driven by stellar sales performance along with the rate of expansion in EBIT margin across all its businesses in Q2FY22. Titan's total revenue excluding bullion segment sales grew by 76

L&T's 2QFY22 operational results were better than estimated, and the margins reported in both the segments were exceptional. Core business performance was affected by COVID challenges and uncertainties, however, margins fared better and wer

ADSEZ's operating performance in 2QFY22 led the EBITDA (ex-forex) to grow 19% YoY to Rs. 22.1bn. Port EBITDA grew +22% YoY with Port margins at 70% vs 70.7% YoY and 70.6% QoQ. Port EBITDA/T stood at Rs. 308 vs. Rs. 306 YoY and INR311 QoQ. In 2QFY22,

Kajaria’s upbeat performance was led by strong volume, capacity utilization at 100% and comfortable transfer of steep gas cost. The company reported a revenue growth of 37% YoY (Rs. 9.7bn) and 20% in H2FY22, volume growth of 25% YoY and 15%

ICICI bank reported robust growth in the recently announced Q2 results, the overall business grew by 19% YoY as the net profit grew to Rs. 55.1bn, NIM grew by 4.0% (up by 11bp QoQ), loan growth stood at 17% YoY and 4% QoQ, NII grew by 25% YoY, fee in